$ICR-PA
InPoint Commercial Real Estate Income, Inc.

2020 Q1 Form 10-Q Financial Statement

#000156459020025116 Filed on May 13, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $6.394M
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.565M $1.981M
YoY Change -21.0%
Operating Profit
YoY Change
Interest Expense $3.962M $2.755M
YoY Change 43.81% 2574.76%
% of Operating Profit
Other Income/Expense, Net -$42.69M $1.765M
YoY Change -2518.53% 5593.55%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$37.86M $3.620M
YoY Change -1145.8% 629.84%
Net Earnings / Revenue -592.09%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 11.35M 6.677M
Diluted Shares Outstanding 11.35M 6.677M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $46.68M $29.99M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $483.1M $271.1M
YoY Change 78.17% 797.37%
SHAREHOLDERS EQUITY
Retained Earnings -$51.19M -$5.934M
YoY Change 762.66% 203.27%
Common Stock $288.0M $188.3M
YoY Change 52.95% 203.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $236.9M $182.4M
YoY Change
Total Liabilities & Shareholders Equity $719.9M $453.5M
YoY Change 58.74% 402.45%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$37.86M $3.620M
YoY Change -1145.8% 629.84%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.982M $1.661M
YoY Change 199.94% 179.63%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$48.49M -$77.21M
YoY Change -37.2% 217.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$23.50M $42.68M
YoY Change -155.06% 111.83%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 52.54M 77.05M
YoY Change -31.8% 174.02%
NET CHANGE
Cash From Operating Activities 4.982M 1.661M
Cash From Investing Activities -48.49M -77.21M
Cash From Financing Activities 52.54M 77.05M
Net Change In Cash 9.036M 1.493M
YoY Change 505.22% -65.75%
FREE CASH FLOW
Cash From Operating Activities $4.982M $1.661M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1417000
CY2019Q4 ck0001690012 Repurchase Agreements Secured By Real Estate Securities
RepurchaseAgreementsSecuredByRealEstateSecurities
107489000
CY2020Q1 ck0001690012 Repurchase Agreements Secured By Commercial Mortgage Loans
RepurchaseAgreementsSecuredByCommercialMortgageLoans
375447000
CY2019Q1 us-gaap Interest Expense
InterestExpense
2755000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3836000
CY2020Q1 ck0001690012 Repurchase Agreements Secured By Real Estate Securities
RepurchaseAgreementsSecuredByRealEstateSecurities
103307000
CY2020Q1 us-gaap Liabilities
Liabilities
483084000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
288030000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-51190000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
236851000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
719935000
CY2020Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
4500000
CY2019Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
0
CY2020Q1 ck0001690012 Amortization Of Deferred Exit Fees
AmortizationOfDeferredExitFees
231000
CY2019Q1 ck0001690012 Amortization Of Deferred Exit Fees
AmortizationOfDeferredExitFees
131000
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
58000
CY2020Q1 ck0001690012 Debt Finance Costs
DebtFinanceCosts
254000
CY2020Q1 ck0001690012 Directors Compensation
DirectorsCompensation
24000
CY2019Q1 ck0001690012 Directors Compensation
DirectorsCompensation
21000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
218000
CY2019Q1 us-gaap Professional Fees
ProfessionalFees
150000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
225000
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
84000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1565000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
1981000
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
4500000
CY2020Q1 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
-38187000
CY2019Q1 us-gaap Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
1808000
CY2019Q1 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
-43000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42687000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1765000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-37858000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.34
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11349448
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11349581
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
24261000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1565000
CY2020Q1 us-gaap Dividends
Dividends
3525000
CY2020Q1 ck0001690012 Adjustments To Additional Paid In Capital Distribution Reinvestment
AdjustmentsToAdditionalPaidInCapitalDistributionReinvestment
-127000
CY2020Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
763000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
142272000
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42680000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
3024000
CY2019Q1 us-gaap Dividends
Dividends
3170000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
182383000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-37858000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
3620000
CY2020Q1 ck0001690012 Amortization Of Equity Based Compensation
AmortizationOfEquityBasedCompensation
8000
CY2019Q1 ck0001690012 Amortization Of Equity Based Compensation
AmortizationOfEquityBasedCompensation
5000
CY2020Q1 ck0001690012 Amortization Of Debt Finance Costs To Operating Expense
AmortizationOfDebtFinanceCostsToOperatingExpense
254000
CY2019Q1 ck0001690012 Amortization Of Debt Finance Costs To Operating Expense
AmortizationOfDebtFinanceCostsToOperatingExpense
195000
CY2020Q1 ck0001690012 Amortization Of Debt Finance Costs To Interest Expense
AmortizationOfDebtFinanceCostsToInterestExpense
19000
CY2019Q1 ck0001690012 Amortization Of Debt Finance Costs To Interest Expense
AmortizationOfDebtFinanceCostsToInterestExpense
22000
CY2020Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
221000
CY2019Q1 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
177000
CY2020Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
360000
CY2019Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
268000
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
159000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-381000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-91000
CY2020Q1 ck0001690012 Increase Decrease In Loans Fees Payable
IncreaseDecreaseInLoansFeesPayable
430000
CY2019Q1 us-gaap Payments To Acquire Mortgage Backed Securities Mbs Categorized As Available For Sale
PaymentsToAcquireMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
14884000
CY2019Q1 us-gaap Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Available For Sale
ProceedsFromSaleOfMortgageBackedSecuritiesMBSCategorizedAsAvailableForSale
9211000
CY2019Q1 ck0001690012 Increase Decrease In Loans Fees Payable
IncreaseDecreaseInLoansFeesPayable
50000
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-138000
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17000
CY2020Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
784000
CY2019Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
350000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-47000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4982000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1661000
CY2020Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
50543000
CY2019Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
72868000
CY2019Q1 us-gaap Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
618000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
2054000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
710000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48489000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77213000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24261000
CY2019Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42680000
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
763000
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1132000
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3024000
CY2020Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
402767000
CY2019Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
269791000
CY2020Q1 ck0001690012 Principal Payments On Securities Sold Under Agreements To Repurchase
PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchase
367307000
CY2019Q1 ck0001690012 Principal Payments On Securities Sold Under Agreements To Repurchase
PrincipalPaymentsOnSecuritiesSoldUnderAgreementsToRepurchase
229099000
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
185000
CY2019Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
381000
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5098000
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
2922000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52543000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77045000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9036000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1493000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37639000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
28497000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
46675000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29990000
CY2019Q1 ck0001690012 Non Cash Change In Deferred Offering Costs And Accrued Offering Expenses Included In Due To Related Parties
NonCashChangeInDeferredOfferingCostsAndAccruedOfferingExpensesIncludedInDueToRelatedParties
-422000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
4100000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
2739000
CY2019Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1189000
CY2020Q1 ck0001690012 Receivable For Real Estate Securities Paydown
ReceivableForRealEstateSecuritiesPaydown
-34000
CY2020Q1 ck0001690012 Related Party Transaction Accrued Stockholder Servicing Fee
RelatedPartyTransactionAccruedStockholderServicingFee
433000
CY2020Q1 ck0001690012 Distribution Reinvestment
DistributionReinvestment
127000
CY2020Q1 ck0001690012 Advisory Agreement Date
AdvisoryAgreementDate
2016-10-25
CY2020Q1 ck0001690012 Shares Authorized
SharesAuthorized
3050000000
CY2019Q2 ck0001690012 Shares Authorized
SharesAuthorized
500000000
CY2019Q2 ck0001690012 Common Stock Shares Authorized Value
CommonStockSharesAuthorizedValue
500
CY2019Q2 ck0001690012 Common Stock Shares Authorized Value
CommonStockSharesAuthorizedValue
3050
CY2020Q1 us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
Cash and cash equivalents include funds on deposit with financial institutions, including demand deposits with financial institutions with original maturities of three months or less.
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46675000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37639000
CY2020Q1 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
36
CY2020Q1 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
556945000
CY2020Q1 ck0001690012 Mortgage Loans On Real Estate Unamortized Costs Net
MortgageLoansOnRealEstateUnamortizedCostsNet
-1109000
CY2020Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.057
CY2020Q1 ck0001690012 Mortgage Loans On Real Estate Weighted Average Maturity Period
MortgageLoansOnRealEstateWeightedAverageMaturityPeriod
P2Y1M6D
CY2019 srt Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
32
CY2019Q4 srt Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
506402000
CY2019Q4 ck0001690012 Mortgage Loans On Real Estate Unamortized Costs Net
MortgageLoansOnRealEstateUnamortizedCostsNet
-1700000
CY2019 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.057
CY2019 ck0001690012 Mortgage Loans On Real Estate Weighted Average Maturity Period
MortgageLoansOnRealEstateWeightedAverageMaturityPeriod
P2Y2M12D
CY2020Q1 us-gaap Mortgage Loans On Real Estate Writedown Or Reserve Amount1
MortgageLoansOnRealEstateWritedownOrReserveAmount1
0
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
546000
CY2020Q1 ck0001690012 Number Of Impaired Loans
NumberOfImpairedLoans
2
CY2020Q1 ck0001690012 Initial Risk Rating For Commercial Mortgage Loans Held For Investment And Real Estate Securities
InitialRiskRatingForCommercialMortgageLoansHeldForInvestmentAndRealEstateSecurities
2
CY2019 ck0001690012 Initial Risk Rating For Commercial Mortgage Loans Held For Investment And Real Estate Securities
InitialRiskRatingForCommercialMortgageLoansHeldForInvestmentAndRealEstateSecurities
2
CY2020Q1 ck0001690012 Number Of Loans Risk Rated Two
NumberOfLoansRiskRatedTwo
28
CY2019 ck0001690012 Number Of Loans Risk Rated Two
NumberOfLoansRiskRatedTwo
30
CY2020Q1 ck0001690012 Number Of Loans Risk Rated Three
NumberOfLoansRiskRatedThree
5
CY2019 ck0001690012 Number Of Loans Risk Rated Three
NumberOfLoansRiskRatedThree
2
CY2020Q1 ck0001690012 Number Of Loans Risk Rated Four
NumberOfLoansRiskRatedFour
1
CY2020Q1 ck0001690012 Number Of Loans Risk Rated Five
NumberOfLoansRiskRatedFive
2
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
133
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
433
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020Q1 ck0001690012 Number Of Commercial Real Estate Loans
NumberOfCommercialRealEstateLoans
24
CY2019Q4 ck0001690012 Number Of Commercial Real Estate Loans
NumberOfCommercialRealEstateLoans
22
CY2020Q1 ck0001690012 Commercial Real Estate Loans Remaining Future Funding Commitment
CommercialRealEstateLoansRemainingFutureFundingCommitment
65527000
CY2019Q4 ck0001690012 Commercial Real Estate Loans Remaining Future Funding Commitment
CommercialRealEstateLoansRemainingFutureFundingCommitment
54620000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2019Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0

Files In Submission

Name View Source Status
0001564590-20-025116-index-headers.html Edgar Link pending
0001564590-20-025116-index.html Edgar Link pending
0001564590-20-025116.txt Edgar Link pending
0001564590-20-025116-xbrl.zip Edgar Link pending
ck0001690012-10q_20200331.htm Edgar Link pending
ck0001690012-20200331.xml Edgar Link completed
ck0001690012-20200331.xsd Edgar Link pending
ck0001690012-20200331_cal.xml Edgar Link unprocessable
ck0001690012-20200331_def.xml Edgar Link unprocessable
ck0001690012-20200331_lab.xml Edgar Link unprocessable
ck0001690012-20200331_pre.xml Edgar Link unprocessable
ck0001690012-ex311_9.htm Edgar Link pending
ck0001690012-ex312_6.htm Edgar Link pending
ck0001690012-ex321_8.htm Edgar Link pending
ck0001690012-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gckio5cxgqqs000001.jpg Edgar Link pending
gckio5cxgqqs000002.jpg Edgar Link pending
gckio5cxgqqs000003.jpg Edgar Link pending
gckio5cxgqqs000004.jpg Edgar Link pending
gckio5cxgqqs000005.jpg Edgar Link pending
gckio5cxgqqs000006.jpg Edgar Link pending
gckio5cxgqqs000007.jpg Edgar Link pending
gckio5cxgqqs000008.jpg Edgar Link pending
gckio5cxgqqs000009.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending